TROJAN-MDR: in vitro activity of cefiderocol and comparators against multidrug-resistant Enterobacterales and Pseudomonas aeruginosa strains in Southern France, evaluation of available testing methods performances
Cefiderocol was highly active against a large collection of MDR GNB, including high-risk clones. It is crucial to assess susceptibility to this last-resort antibiotic using a validated method when considering clinical use.
Authors
- Alix Pantel (ORCID: https://orcid.org/0000-0002-2317-4199)
- Romaric Larcher (ORCID: https://orcid.org/0000-0002-7591-0901)
- Vincent Jean-Pierre (ORCID: https://orcid.org/0000-0002-0433-0141)
- Hélène Marchandin (ORCID: https://orcid.org/0000-0003-2130-6335)
- Marine Gaillard
- Chloé Magnan (ORCID: https://orcid.org/0000-0002-2330-212X)
- Adeline Boutet-Dubois
- Madjid Morsli (ORCID: https://orcid.org/0000-0002-8074-1794)
- Jean-Philippe Lavigne
- Massinissa Benyahia
- Stéphanie Genieyz
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Laboratoire HydroSciences Montpellier (FR)
- Physiologie et Médecine Expérimentale du Coeur et des Muscles (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Institut de Recherche pour le Développement (FR)
- Université de Nîmes (FR)
Publication Details
- Journal
- Annals of Clinical Microbiology and Antimicrobials
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1186/s12941-025-00785-9
- Citations
- 2
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.18
Funders
- Shionogi
- Centre Hospitalier Universitaire de Nîmes